Provided is a pharmaceutical composition for treatingand/or preventing abnormal bone metabolism targeting a proteinencoded by a gene strongly expressed in osteoclasts.Specifically provided is a pharmaceutical compositioncontaining an antibody which specifically recognizes humanSiglec-15 and has an activity of inhibiting osteoclastformation, and the like.